Variable | Group without conduction disorders (n = 35) | Group with conduction disorders (n = 33) | P value |
---|---|---|---|
Sex (male) | 21 (60.0%) | 14 (42.4%) | 0.225 |
Age (years) | 76.63 ± 7.42 | 72.31 ± 8.4.2 | 0.135 |
BMI (kg/m2) | 21.25 ± 2.70 | 20.87 ± 2.72 | 0.697 |
STS score | 7.69 ± 1.25 | 8.13 ± 1.75 | 0.422 |
Past medical history | |||
Hypertension | 24 (68.6%) | 21 (63.6%) | 0.799 |
Coronary heart disease | 7 (20.0%) | 10 (30.3%) | 0.406 |
Diabetes | 3 (8.6%) | 7 (21.2%) | 0.259 |
Laboratory data | |||
Leukocyte count (*109/L) | 5.61 ± 1.62 | 4.83 ± 1.11 | 0.119 |
Red blood cells count(*1012/L) | 3.94 ± 0.58 | 3.87 ± 0.46 | 0.694 |
Hemoglobin level (g/L) | 117.13 ± 18.3 | 117.56 ± 13.75 | 0.940 |
Platelet count (*109/L) | 157.50 ± 60.54 | 157.75 ± 52.25 | 0.990 |
Total cholesterol level (mmol/L) | 3.73 ± 0.82 | 3.77 ± 1.29 | 0.913 |
Low-density cholesterol level (mmol/L) | 2.00 ± 0.72 | 2.10 ± 0.91 | 0.736 |
Creatinine level (µmol/L) | 89.08 ± 30.70 | 85.78 ± 41.68 | 0.800 |
Fasting glucose level (mmol/L) | 4.66 ± 0.55 | 4.96 ± 0.78 | 0.224 |
High-sensitivity troponin level (ng/mL) | 0.009 (0.008,0.020) | 0.010 (0.005,0.028) | 0.742 |
CKMB level (U/L) | 16.05 ± 4.71 | 13.86 ± 3.59 | 0.095 |
BNP level (pg/mL) | 294 (100,766) | 260 (156,425) | 0.368 |
Electrocardiography findings | |||
Preoperative QRS width (ms) | 104.06 ± 21.82 | 107.63 ± 23.2 | 0.658 |
Preoperative cRBBB or first-degree AV block | 4 (11.4%) | 8 (24.2%) | 0.166 |
Echocardiography | |||
LA (mm) | 44.56 ± 5.27 | 41.56 ± 7.30 | 0.193 |
LV (mm) | 55.05 ± 7.29 | 59.57 ± 9.51 | 0.086 |
IVS (mm) | 9.97 ± 1.32 | 9.81 ± 2.32 | 0.817 |
LVEF (%) | 52.25 ± 8.70 | 53.63 ± 10.46 | 0.689 |
Mitral curtain length | 4.88 ± 1.20 | 4.94 ± 1.12 | 1 |
LVOT type (non-tubular) | 14 (29.6%) | 16(80%) | 0.008 |
CT data | |||
Mean diameter of AA (mm) | 24.29 ± 2.19 | 24.72 ± 2.84 | 0.639 |
Mean diameter of LVOT (mm) | 24.80 ± 3.21 | 2465 ± 3.72 | 0.904 |
Mean diameter of STJ (mm) | 35.13 ± 3.39 | 34.68 ± 3.84 | 0.728 |
Angle of the aortic root (°) | 55.23 ± 5.99 | 61.48 ± 8.72 | 0.009 |
Mean diameter of AAO (mm) | 42.96 ± 2.67 | 41.55 ± 5.22 | 0.345 |
AA calcification | 4 (11.4%) | 5 (15.2%) | 0.730 |
LVOT calcification | 2 (5.7%) | 2 (6.1%) | 1 |
Valve device and TAVR intervention procedure dates | |||
Valve device type (mm) | 28.8 ± 1.897 | 28.6 ± 1.92 | 0.776 |
Valve implantation depth (mm) | 0.00 (0.00, 4.00) | 5.92 (3.31 6.13) | 0.001 |
Others | |||
Largest diameter of the upper corolla of the valve device/diameter of AAO | 1.00 ± 0.06 | 1.05 ± 0.12 | 0.170 |
Diameter of the inferior edge of valve device/diameter of aortic annular | 1.25 ± 0.07 | 1.23 ± 0.08 | 0.618 |
Diameter of the inferior edge of valve device/Mean diameter of LVOT | 1.24 ± 0.11 | 1.25 ± 0.13 | 0.705 |
Mean diameter of LVOT/Mean diameter of aortic annular | 1.02 ± 0.07 | 1.00 ± 0.06 | 0.308 |